Naloxone and vitamin E block stress-induced reduction of locomotor activity and elevation of plasma corticosterone

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 7, 1999, Pages 462-467

  Ainsah, O ^a   Nabishah, B M ^a   Osman, C B ^a   Khalid, B A K ^a,b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Locomotor activity; Plasma corticosterone; Restraint stress; Vitamin e

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CORTICOSTERONE; NALOXONE; NARCOTIC ANTAGONIST; OPIATE; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032720598     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212139     Document Type: Article

References (51)

1. Al-Shabanah-OA, Mostafa YH, Hassan MT, Khairaldin-AA, AL-Sawaf-HA: Vitamin E protects against bacterial endotoxin-induced increase of plasma corticosterone and brain glutarnate in the rat. Res Commu Mol Pathol Pharmacol 92: 95-105, 1996
2. Armario A, Campmany L, Borras M, Hidalgo J: Vitamin E-supplemented diets reduce lipid peroxidation but do not alter either pituitary-adrenal glucose and lactate responses to immobilisation stress or gastric ulceration. Free Radic Res Commun. 9:113-118, 1990
3. Awasthi D, Church DF, Torbati D, Carey ME, Pryor WA: Oxidative stress following traumatic brain injury in rats. Surg Neurol 47: 575-581, 1997
4. Bloom F. β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367-1369, 1976.
5. Buckingham JC, Cooper TA: Effects of Naloxone on hypothalomo-pituitary-adrenocortical activity in the rat. Neuroendocrinology 42: 421-426, 1986
6. Buckingham JC, Cooper TA: Interrelationships of opiodergic and adrenergic mechanisms controlling the secretion of corticotrophin releasing factor in rat. Neuroendocrinology 46: 199-206, 1987
7. Carlsten J, Bjurstrom S, Haggendal J, Jonsson L: Reduction of heart lesions after experimental restraint stress; a study in stress susceptible pigs. Zentralbl Veterinar med-A 41: 722-730, 1994
8. Carr DB, Bullen BA, Skrinar GS: Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med 305: 560-563, 1981
9. Clarkson PM. Antioxidants and physical performance. Crit Rev Food Sci Nutr 35: 131-141, 1995
10. Curzon G, Kennet GA, Sarna GS, Whitton PS: The effects of Tianeptin and other antidepressants on a rat model of depression. Brit J of Psychiatry 160, 51-55, 1992
11. Dubois M, Pickar, D, Cohen MR: Surgical stress in humans is accompanied by an increase in plasma beta-endorphin-immunore-activity. Life Sci 29: 1249-1254, 1981
12. Dijken HHV, Heyden JAMVD, Mos J, Tilders FJH: Inescapable footshocks induce progressive and long -lasting behavioral changes in male rats. Physiol Behav 51: 787-794, 1992
13. Eisenberg RM: Effects of naloxone on plasma corticosterone in the opiate-naïve rat. Life Sci. 26: 935-943, 1980
14. Faden AI, Holaday JW: Experimental endotoxin shock: The pathophysiologic function of endorphins and treatment with opiate antagonists. J. Infectious Dis 142: 229-238, 1980a
15. Faden AI, Holaday JW: Naloxone treatment of endotoxin shock: Stereospecificity of physiologic and pharmacologic effects in the rat. J Pharm Exp Ther 212: 441-447, 1980b
16. Faden AI, Holaday JW: Opiate antagonist: a role in the treatment of hypovolemic shock. Science 205: 317-318, 1979
17. Feurstein G, Ailam R, Bergman F: Reversal by naloxone of hemorrhagic shock in anephric cats. Eur J Pharmacol 65: 93-96, 1980
18. Fuhrmann H., Sallmann-H.P: Alpha-tocopherol and phospholipase A2 in liver and brain of chicks posthatching: the influence of dietary fat and vitamine E. Ann Nutr Metab 39: 302-309, 1995
19. Gahhos FN, Chiu RCJ, Hinchey EJ, Richards GK: Endorphins in Septic shock. Arch of Surgery. 117: 1053-1057, 1982
20. Gibson A, Ginsburg M, Hall M, Hart SL: The effects of opiate receptors agonists and antagonists on the stress-induced-secretion of corticosterone in mice. Br J Pharmacol 65: 139-146, 1979
21. Guilleman R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale CRW, Bloom F: β-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197: 1367-1369, 1977
22. Haleem DJ: Adaptation to repeated restraint stress in rats: failure of ethanol-treated rats to adapt in the stress schedule. Alcohol 31: 471-477, 1996
23. Haraez JL, Bloom AS, Wang RIH, Tseng LF: Effect of intra ventricular beta-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary beta-endorphin. Neuroendocrinology 33: 170-175, 1981
24. Hayes AG, Stewart BR: Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels. Eur J Pharmacol 116: 75-79, 1985
25. Horwitt MK: The promotion of vitamin E. J. Nutr 116: 1371-1377, 1986
26. Iyengar S, Kim HS, Wood PL: Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharmacol Exp Ther 238: 429-436, 1986
27. Katz RJ. Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacology, Biochemistry Behavior, 16: 965-968, 1982
28. Kelly EE; Buettner GR.; Burns CP: Relative alpha-tocopherol deficiency in cultured cells: free radical-mediated lipid peroxidation, lipid oxidizability, and cellular polyunsaturated fatty acid content. Arch Biochem Biophys 319: 102-109, 1995
29. Kennet GA Dickinson, SL, Curzon G. Enhancement of some 5-HT-dependent behavioural responses following repeated immibilization in rats. Brain Res 330: 253-263, 1985
30. Komiyama K, Iizuka K, Ymaoka M, Watanabe H, Tsuchiya N Umezawa I. Studies on biological activity of tocotrienols. Chem Pharmaco Bull 37: 1369-1371, 1989
31. Koplik EV, Salieva RM, Gorbunova AV: The open-field test as a prognostic criterion of resistance to emotional stress in Wistar rats. Vyssh Ner Deiat Im I P Pavlova 45: 775-781, 1995
32. Khalid BAK, Paden M & Zainuddin M: The effects of naloxone, dexamethasone, deoxycorticosterone and 17-hydroxy-progesterone on blood pressure responses of normal and adrenalectomized rats during hypovolemic shock. Clin and Exp Pharm Physiol 14: 111-117, 1987
33. Kuo JH, Chen HW, Chow RG, Lii CK: Vitamin E protection of cell morphology under oxidative stress is related to cytoskeletal proteins in rats hepatocytes. Arch Toxicol 71: 231-237, 1997
34. Lim AT, Funder JW: Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive β-endorphin: Effects of diurnal variation, adrenalectomy corticosteroids and opiate agonists and antagonists. Neuroendocrinology 35: 225-234, 1983
35. Morgan GE and Mikhail MS: Clinical Anesthesiology. Adjuncts to anesthesia. First Edition, p 184, Appleton & Lange, Norwalk, Connecticut, 1992
36. Mundron P; Kuvac G; Bartko P; Choma J; Zezula I: The effect of vitamin E on cortisol and lactate levels and on the acid base equilibrium in calves exposed to transportation stress. Vet Med Praha 41: 71-76, 1996
37. Musial J, Domagala TB, Szczeklik: Vitamin E -Its usefulness in health and in curing diseases. In: Mino M, Nakamura H, Diplock AT, Kayden HJ (eds.). Lipid peroxidation, vitamin E and cardiovascular. disease. First Edition. Pp 275,279, Japan Sci. Soc. Press, Tokyo / S. Karger, Basel, 1993
38. Nordin M, Morat P, Zainora M: The effect of endogenous opiods on blood pressure during Stress. Clin and Exp Pharm Physiol 14: 303-308; 1987
39. Pechnick RN, George R, Poland RE: Identification of multiple opiates receptors through neuruendocrine responses. Antagonism of mu, kappa and sigma agonists by naloxone. J Pharmacol Exp Ther 232: 170-177, 1985
40. Pryor WA, Ames B.M, Mcord RC, Harman D: Oxygen radicals and human disease. Annal Intern Med 107: 526-545, 1987
41. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB-J 9: 526-533, 1995
42. Ruzymah BHI, Nabishah B.M,. Aminuddin S, Khalid BAK: .Mineralocorticoid and glycyrrhizic acid block stress induced hyotension in rats. J Clin and Exp Hypertension 22: 35-39; 1995
43. Sies H, Stahl W: Vitamin E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr. 62: 1315s-1321s., 1995
44. Shaheen AA, Hamdy MA, Kheir-Eldin AA, Lindstrom P, Abd El-Fattah AA: Effect of pretreatment with vitamin E or Diazepam on brain metabolism of stressed rats. Biochem Pharmacology 46: 194-197, 1993
45. Taylor CG, Mc Cutchon TL., Boermans HJ., DiSilvestro RA, Bray T.M. Comparison of Zn and vitamin E for protection against hyperoxia induced lung damage. Free Radic Biol Med 22: 543-550, 1997
46. Vuchetich PJ, Bagchi D, Bagchi M, Hassoun EA, Tang L, Stohs SJ,: Naftalin induced oxidative stress in rats and the protective effect of vit E succinate. Free radical Biology Medicine 21: 570-590, 1996
47. Wan Nazaimoon WM, Sakinah O, Gapur A, Khalid BAK: Effects of palm olein tocopherol and tocotrienol on lipid peroxidation, lipid profiles and glycemic control in non-insulin Diabetes Mellitus patients. Nutrition Research 16: 1901-1911, 1996
48. Wolf R, Wolf D Ruocco V: Vitamin E: the radical protector. J Eur Acad Dermatol Venereol 10: 103-117, 1998
49. Xu R. K.; McCann S. M: Differential effects of naloxone on basal and stress-induced release of ACTH and prolactin in the male rat. Life Sci 45: 1591-1599, 1989
50. Zerani M, Gobetti A: Effects of beta-endorphin and naloxone on corticosterone and cortisol release in the newt (Triturus carnifex): studies in vivo and in vitro. J Endocrinol: 131, 295-302, 1991
51. Zerani M, Gobetti A: In vivo and in vitro effects of beta-endorphin and naloxone on corticosterone and cortisol release in male and female water frog, Rana esculenta. Comp Biochem Physiol C102: 537-542, 1992.